GAMCO Investors’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

GAMCO Investors’s Portfolio PSTX Stock Details PSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-20,000	Closed	-$192K	–	897
2024 Q4	$192K	Buy	+20,000	New	+$104K	﹤0.01%	837

Other funds holding PSTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

GAMCO Investors's PSTX Position: Q1 2025 in Review

GAMCO Investors sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 20,000 shares — an estimated $192K sold.

GAMCO Investors first reported a position in PSTX in Q4 2024 and held it in 1 quarter. The position peaked at $192K in Q4 2024. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

GAMCO Investors reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
GAMCO Investors sold 20,000 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $192K.
GAMCO Investors first reported a position in Poseida Therapeutics, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
GAMCO Investors's Poseida Therapeutics, Inc. Common Stock position peaked at $192K in Q4 2024.
1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on GAMCO Investors's 13F filing for Q1 2025, filed 14 May 2025.